| Real-World Effectiveness and Safety of Pegcetacoplan in Patients With C3G or IC-MPG: A Multi-Country Study (NCT07746895) | Swedish Orphan Biovitrum | 2026-07-09 |
| A Study to Evaluate Efficacy and Safety of Anakinra in Chinese Patients With Colchicine-resistent FMF (NCT06666335) | Swedish Orphan Biovitrum | 2026-03-01 |
| A Non-interventional, Post-Marketing Study to Describe Outcome of Nitisinone Treatment in HT-1 Patients (NCT06227429) | Swedish Orphan Biovitrum | 2025-09-01 |
| An Efficacy and Safety Study of Subcutaneous Anakinra in Chinese Patients With Systemic Juvenile Idiopathic Arthritis (SJIA) and Adult-Onset Still's Disease (AOSD) (NCT07706868) | Swedish Orphan Biovitrum | 2025-09-01 |
| Assessment of Macrophage Activation syndromE in STill's Disease in Italy (NCT06992505) | Swedish Orphan Biovitrum | 2025-06-06 |
| A Study to Assess the Effectiveness and Safety of Pacritinib in Patients With VEXAS Syndrome (PAXIS) (NCT06782373) | Swedish Orphan Biovitrum | 2025-05-28 |
| Long-term Study Evaluating Joint Health in People With Haemophilia A Receiving Real-world Prophylactic Treatment With Efanesoctocog Alfa (NCT06940830) | Swedish Orphan Biovitrum | 2025-05-21 |
| Study to Provide Continued Access to Treatment for Patients Completing a Previous Trial With Efanesoctocog Alfa (NCT06716814) | Swedish Orphan Biovitrum | 2025-03-06 |
| Pharmacokinetic Comparison of Efanesoctocog Alfa vs Other EHL-rFVIII Products in Participants With Severe Haemophilia A (NCT06579144) | Swedish Orphan Biovitrum | 2025-02-24 |
| A Study to Investigate the Course of Synovial Hypertrophy in Patients With Haemophilia A on Efanesoctocog Alfa Prophylaxis (NCT06752850) | Swedish Orphan Biovitrum | 2024-12-19 |
| Assessment of Macrophage Activation syndromE in STill's Disease (NCT06405152) | Swedish Orphan Biovitrum | 2023-09-27 |
| An 18-month Low-interventional Study to Assess Joint Health in Haemophilia A and B Patients on Prophylaxis With Efmoroctocog Alfa or Eftrenonacog Alfa (NCT05856266) | Swedish Orphan Biovitrum | 2023-08-24 |
| A Study Evaluating Physical Activity and Joint Health in Severe Haemophilia A Patients ≥12 Years Treated Once Weekly With Efanesoctocog Alfa (NCT05817812) | Swedish Orphan Biovitrum | 2023-07-31 |
| A Real World Effectiveness Study of Pegcetacoplan in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) (NCT05776472) | Swedish Orphan Biovitrum | 2023-06-26 |
| A Post-authorization Study to Describe the Safety and Efficacy of Emapalumab for the Treatment of pHLH in Treatment Experienced Chinese Patients (NCT05744063) | Swedish Orphan Biovitrum | 2023-02-03 |
| A Study to Evaluate the Efficacy and Safety of Pegcetacoplan in Patients With Cold Agglutinin Disease (CAD) (NCT05096403) | Swedish Orphan Biovitrum | 2022-10-20 |
| A Study of Anakinra in Japanese Patients With Still's Disease (SJIA and AOSD) (NCT05814159) | Swedish Orphan Biovitrum | 2022-08-24 |
| An Observational, Multicenter Study to Evaluate the Use and Effectiveness of Doptelet® in Patients With ITP (NCT04943042) | Swedish Orphan Biovitrum | 2022-02-22 |
| A Study of Pegcetacoplan for Patients With Transplant-associated Thrombotic Microangiopathy After Hematopoietic Stem Cell Transplantation (NCT05148299) | Swedish Orphan Biovitrum | 2022-02-01 |
| Study to Investigate the Pharmacokinetics, Pharmacodynamics and Assess the Efficacy and Safety to Support Dose Selection of Emapalumab in Pre-empting Graft Failure in Patients at High Risk After HSCT. (NCT04731298) | Swedish Orphan Biovitrum | 2021-05-25 |
| Psychometric Validation of the Hemophilia Functional Ability Scoring Tool (Hemo-FAST) (NCT04731701) | Swedish Orphan Biovitrum | 2021-05-05 |
| A Study to Evaluate Emapalumab in Japanese Healthy Volunteers. (NCT04765553) | Swedish Orphan Biovitrum | 2021-01-14 |
| A Study of SEL-212 in Patients With Gout Refractory to Conventional Therapy II (NCT04596540) | Swedish Orphan Biovitrum | 2020-11-30 |
| A Clinical Study to Investigate Interferon Gamma (IFNɣ) Signature in Patients Post HSCT and in Patients With Impaired HSC Proliferation Pre-transplant (NCT04494061) | Swedish Orphan Biovitrum | 2020-11-16 |
| A Study of SEL-212 in Patients With Gout Refractory to Conventional Therapy (NCT04513366) | Swedish Orphan Biovitrum | 2020-08-18 |
| A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Emapalumab in Adult Patients With HLH (NCT03985423) | Swedish Orphan Biovitrum | 2020-06-02 |
| A 48-Month Study to Evaluate Long-Term Effectiveness of Elocta on Joint Health (NCT04293523) | Swedish Orphan Biovitrum | 2020-03-30 |
| Impact on French Physician's Haemophilia Treatment Management Decision Based on Systematic Joint Examination (NCT04133883) | Swedish Orphan Biovitrum | 2020-01-13 |
| An International Study to Evaluate the Real-world Effectiveness and Usage of Alprolix in Patients With Haemophilia B (NCT03901755) | Swedish Orphan Biovitrum | 2019-09-12 |
| Long-term Safety Study of Kineret® in Patients With Systemic Juvenile Idiopathic Arthritis (SJIA) (NCT03932344) | Swedish Orphan Biovitrum | 2019-04-10 |
| Study to Assess the Efficacy and Safety of Emapalumab in Primary Haemophagocytic Lymphohistiocytosis (NCT03312751) | Swedish Orphan Biovitrum | 2019-02-06 |
| A Study to Assess the Safety, Tolerability, and Efficacy of Long-term SOBI003 Treatment in Pediatric MPS IIIA Patients (NCT03811028) | Swedish Orphan Biovitrum | 2019-01-19 |
| rFVIIIFc (Elocta®) ITI Chart Review in Patients With Haemophilia A (NCT03951103) | Swedish Orphan Biovitrum | 2018-11-07 |
| Management of Health-Related QoL Impairment, Including Pain, Depression and Anxiety, in People With Haemophilia A and B (NCT03276130) | Swedish Orphan Biovitrum | 2018-10-30 |
| A Study to Evaluate the Real-world Effectiveness and Usage of Alprolix in Patients With Haemophilia B in France (NCT03655340) | Swedish Orphan Biovitrum | 2018-09-12 |
| A Study to Assess the Safety and Tolerability of SOBI003 in Pediatric MPS IIIA Patients (NCT03423186) | Swedish Orphan Biovitrum | 2018-06-19 |
| A Study to Investigate the Safety and Efficacy of Emapalumab, an Anti-IFN-gamma mAb in Patients With Systemic Juvenile Idiopathic Arthritis (sJIA) or Adult-onset Still's Disease (AOSD) Developing Macrophage Activation Syndrome/Secondary HLH (MAS/sHLH) (NCT03311854) | Swedish Orphan Biovitrum | 2018-02-20 |
| A Study to Evaluate Efficacy and Safety of Anakinra in the Treatment of Still's Disease (SJIA and AOSD) (NCT03265132) | Swedish Orphan Biovitrum | 2017-09-26 |